The macrocyclic lactone oxacyclododecindione reduces fibrosis progression

Background: Renal fibrosis is one of the most important triggers of chronic kidney disease (CKD), and only a very limited number of therapeutic options are available to stop fibrosis progression. As fibrosis is characterized by inflammation, myofibroblast activation, and extracellular matrix (ECM) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Saurin, Sabrina, Meineck, Myriam, Rohr, Markus, Roth, Wilfried, Opatz, Till, Erkel, Gerhard, Pautz, Andrea, Weinmann-Menke, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294233/
https://www.ncbi.nlm.nih.gov/pubmed/37383717
http://dx.doi.org/10.3389/fphar.2023.1200164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294233/
https://www.ncbi.nlm.nih.gov/pubmed/37383717
http://dx.doi.org/10.3389/fphar.2023.1200164

Ejemplares similares